OraSure Technologies, Inc. develops, manufactures and markets diagnostic products and specimen-collection technologies used by healthcare providers, laboratories, researchers and consumers. The company focuses on making testing more accessible through products that support decentralized, point-of-care and at-home testing, as well as laboratory-based molecular and diagnostic workflows.
Its portfolio has included the OraQuick line of rapid diagnostic tests, including oral-fluid tests for HIV and hepatitis C, along with other infectious-disease testing products. OraSure also provides oral-fluid and other specimen-collection devices, preservation systems and related laboratory solutions. Through its DNA Genotek business, the company supplies collection kits and stabilization technologies used in genomics, biobanking, clinical research and molecular testing.
OraSure serves customers in the United States and international markets through direct sales, distributors, commercial partners, government programs and online channels. Its products are used across public health, clinical care, pharmaceutical research, consumer health and academic research. The company is headquartered in Bethlehem, Pennsylvania, and has built its business around expanding access to diagnostic testing and improving the collection and analysis of biological samples.
AI Generated. May Contain Errors.
